1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsR41 Small Business Technology Transfer (STTR) Phase I is sponsored by NIH. Supports cooperative research and development between small businesses and research institutions to commercialize innovative technologies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Technology Transfer (STTR) Grants - Phase I (R41) | Grants & Funding U.S. Department of Health and Human Services National Institutes of Health Small Business Technology Transfer (STTR) Grants - Phase I (R41) To help small businesses that partner with a nonprofit research institution bring scientific innovations to the marketplace.
The STTR supports research and development (R&D) awards to eligible United States small business concerns only. The focus of a Phase 1 award is on the feasibility, technical merit, and commercial potential of the research project. Carefully read the Eligibility section of the funding opportunity for opportunity-specific organization eligibility requirements.
Project Director/ Principal Investigator (PD/PI) Eligibility PD/PI must be employed by either the partnering research institution or small business. Carefully read the Eligibility section of the funding opportunity for opportunity-specific PD/PI eligibility requirements. Small Business Technology Transfer (STTR) Grants - Phase I Use the Explore NIH Grant Opportunities tool to search Grants.
gov. Ready to develop your application? Learn from a step-by-step guide. Standard Due Dates apply.
AIDS and AIDS-Related Applications Beginning with applications for Advisory Council Review in January 2027 (i.e., application due dates on or after May 25, 2026), NIH will no longer accept applications submitted on dedicated AIDS application due dates. ( NOT-OD-26-029 ) Standard Application Due Dates (when applicable) NIH SEED: Understanding SBIR and STTR website NIH Grants Policy Statement Section 18.
5 Small Business Innovation Research and Small Business Technology Transfer Programs For technical issues E-mail OER Webmaster
According to the current listing, eligibility includes: Small businesses and research institutions. Confirm the full requirements in the official notice before applying.
The current listing shows up to $300,000 over one year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
R41 Small Business Technology Transfer (STTR) Phase I is funded by NIH. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article